| Bioactivity | Pegaldesleukin is a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2). Pegaldeslukin has antiviral activity and has potential applications in HIV, possibly delaying the progression of HIV infection by retaining the immune repertoire[1][2][3]. |
| Name | Pegaldesleukin |
| CAS | 141752-91-2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Vet—QL03AC01 A T C. Interleukin-2[J]. Lancet, 1992, 339: 1061. [2]. Sharma G, et al. Compositions and methods for treating viral infections. United States. US20100081713. [3]. Carr A. Interleukin-2 may delay HIV progression[J]. Inpharma, 1998, 1165: 28. |